Press Releases
Dr. Reddy’s enters into collaboration with Henlius for commercialisation of daratumumab
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories, today announced that it has entered into a license agreement…
Vistagen receives US patent for AV-101 to treat neuropathic pain
Vistagen, a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today…
Auron announces FDA clearance to initiate clinical development of AUTX-703
Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced…
Enveric Biosciences and Restoration Biologics announce licensing agreements to treat joint disease
Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety,…
BioNTech Completes Acquisition of Biotheus
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of Biotheus (“Biotheus”), a clinical-stage biotechnology…
Jaguar Health announces first patient dosed in SBS-IF in investigator-initiated trial of Crofelemer
Jaguar Health family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that the first short bowel syndrome with intestinal failure (SBS-IF) patient has…
Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal…
Sarclisa with standard-of-care VRd approved in China for patients with newly diagnosed multiple myeloma
The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and…
US FDA approves Celltrion’s AVTOZMA, a biosimilar to ACTEMRA
Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous…
Orion and Invenra announce discovery service and commercial license agreement
Orion Corporation and Invenra, an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today announced that they have…